[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.47.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1980

Copper Ligands in Human Milk: A Vehicle for Copper Supplementation in the Treatment of Menkes' Disease?

Author Affiliations

Department of Nutrition University of California Davis, CA 95616

Am J Dis Child. 1980;134(8):802-803. doi:10.1001/archpedi.1980.02130200070029
Abstract

To the Editor.—Recent results from our laboratory have shown that human milk, unlike cow's milk, contains a low-molecular-weight (LMW) zinc complex,1 now identified as zinc citrate.2 We have therefore hypothesized that the therapeutic value of human milk in the treatment of acrodermatitis enteropathica (AE), a genetic disorder of zinc metabolism, is due to the presence of this complex, which is thought to be highly available for absorption.3,4

Assuming that human milk may contain LMW copper as well as zinc complexes, Williams et al5 have suggested that human milk may also be of therapeutic value in the treatment of Menkes' kinky hair disease, a sexlinked genetic disorder in humans that is manifested by abnormal intestinal copper absorption and many characteristics similar to those of copper-deficient animals.6 Despite the aggressive use of copper in infants with Menkes' disease, the prognosis for these patients has not improved.

×